Amgen

Description

Amgen develops and manufactures biologic medicines using living cells, conducts R&D across oncology, hematology, bone health, inflammation, cardiovascular disease, neurology, and nephrology, and applies machine learning to molecule selection and process efficiency.

Related

• Age LabsAge Labs develops biomarkers and predictive algorithms for early detection of age-related diseases, offering diagnostic tests, biological…
• AivenAiven provides a managed open-source data platform that streams, stores, and serves data across major cloud providers and connects AI…
• ALLOXALLOX uses high-throughput experiments with genetics and AI to learn biophysical parameters of protein function, supporting systematic…
• AMADIXAMADIX develops blood-based liquid biopsy tests and machine-learning software that analyze molecular biomarkers and clinical data to detect…
• APCAPC provides process development services and technology platforms that accelerate pharmaceutical and biologics development for pharma and…
• ARSENALE BIOYARDSARSENALE BIOYARDS builds an integrated platform combining hardware, data, and AI to enable precision fermentation from lab‑scale organism…
• Aukera Therapeutics GmbHAukera Therapeutics GmbH develops the first RAPTOR inhibitors, using an AI-driven drug discovery platform and mTOR biology expertise to…
• BICO GroupBICO Group provides lab automation software, purified ECM proteins, and 3D bioprinters used in tissue engineering, 3D bioprinting, cell…
• BiolevateBiolevate provides an evidence-grade AI platform that orchestrates governed, auditable workflows for life-sciences teams to generate, link,…